Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 1.76% is 370% above its 5-year average of 0.37%, near the low end of its 5-year range (-23.06%–61.59%).
313.38% above its 12-month average of -0.82%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -23.06%.
NET PROFIT MARGIN
1.76%
NET PROFIT MARGIN AVG TTM
-0.82%
NET PROFIT MARGIN AVG 3Y
10.60%
NET PROFIT MARGIN AVG 5Y
0.37%
NET PROFIT MARGIN AVG 10Y
-1.61%
NET PROFIT MARGIN AVG 15Y
-1.36%
NET PROFIT MARGIN AVG 20Y
-1.13%
CURRENT VS TTM AVG
+313.38%
CURRENT VS 3Y AVG
-83.40%
CURRENT VS 5Y AVG
+370.05%
CURRENT VS 10Y AVG
+209.50%
CURRENT VS 15Y AVG
+229.75%
CURRENT VS 20Y AVG
+255.24%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 631 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
MiMedx Group, Inc.
Market Cap
$665.40M
Net Profit Margin
1.76%
TTM Avg
-0.82%
3Y Avg
10.60%
5Y Avg
0.37%
Market Cap
$666.36M
Net Profit Margin
-194.74%
TTM Avg
-217471.40%
3Y Avg
-109716.20%
5Y Avg
-73279.44%
Market Cap
$666.95M
Net Profit Margin
329.09%
TTM Avg
-11813.45%
3Y Avg
-10636.53%
5Y Avg
-14431.57%
Market Cap
$643.45M
Net Profit Margin
-115.18%
TTM Avg
-291.05%
3Y Avg
-192.01%
5Y Avg
-153.55%
Market Cap
$695.21M
Net Profit Margin
-4619.67%
TTM Avg
-3871.87%
3Y Avg
-2595.36%
5Y Avg
-1815.29%
Market Cap
$636.48M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$640.57M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$704.02M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiMedx Group, Inc. (MDXG) | $665.40M | 1.76% | -0.82% | 10.60% | 0.37% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $666.36M | -194.74% | -217471.40% | -109716.20% | -73279.44% |
| Helus Pharma Inc. (HELP)vs › | $666.95M | 329.09% | -11813.45% | -10636.53% | -14431.57% |
| Annexon, Inc. (ANNX)vs › | $679.13M | 0.00% | 0.00% | 0.00% | 0.00% |
| OmniAb, Inc. (OABI)vs › | $643.45M | -115.18% | -291.05% | -192.01% | -153.55% |
| Anteris Technologies Global Corp. (AVR)vs › | $695.21M | -4619.67% | -3871.87% | -2595.36% | -1815.29% |
| Climb Bio, Inc. (CLYM)vs › | $636.48M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aura Biosciences, Inc. (AURA)vs › | $640.57M | 0.00% | 0.00% | 0.00% | 0.00% |
| Faeth Therapeutics, Inc. (FTH)vs › | $704.02M | 0.00% | 0.00% | 0.00% | 0.00% |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $707.95M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
15.3%
Net Profit Margin
1.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -23.06% |
| 2026-03-31 | -18.41% |
| 2025-12-31 | 12.86% |
| 2025-09-30 | 14.73% |
| 2025-06-30 | 9.75% |
| 2025-03-31 | 7.96% |
| 2024-12-31 | 8.01% |
| 2024-09-30 | 9.63% |
| 2024-06-30 | 20.21% |
| 2024-03-31 | 10.93% |
| 2023-12-31 | 61.59% |
| 2023-09-30 | 10.44% |
| 2023-06-30 | 1.48% |
| 2023-03-31 | -6.95% |
| 2022-12-31 | -0.56% |
| 2022-09-30 | -12.45% |
| 2022-06-30 | -16.25% |
| 2022-03-31 | -17.81% |
| 2021-12-31 | 3.29% |
| 2021-09-30 | -3.71% |
| 2021-06-30 | -2.61% |
| 2021-03-31 | -13.98% |
| 2020-12-31 | -24.19% |
| 2020-09-30 | -30.20% |
| 2020-06-30 | -15.78% |
| 2020-03-31 | -7.81% |
| 2019-12-31 | -9.79% |
| 2019-09-30 | 13.93% |
| 2019-06-30 | -25.52% |
| 2019-03-31 | -19.94% |
| 2018-12-31 | -39.12% |
| 2018-09-30 | -0.20% |
| 2018-06-30 | 1.89% |
| 2018-03-31 | 5.49% |
| 2017-12-31 | 39.83% |
| 2017-09-30 | 20.64% |
| 2017-06-30 | 10.56% |
| 2017-03-31 | 5.96% |
| 2016-12-31 | 7.84% |
| 2016-09-30 | 5.15% |
| 2016-06-30 | 3.44% |
| 2016-03-31 | 2.24% |
| 2015-12-31 | 25.81% |
| 2015-09-30 | 13.37% |
| 2015-06-30 | 11.89% |
| 2015-03-31 | 10.03% |
| 2014-12-31 | 9.68% |
| 2014-09-30 | 11.04% |
| 2014-06-30 | -1.53% |
| 2014-03-31 | -4.71% |
| 2013-12-31 | -7.93% |
| 2013-09-30 | -1.91% |
| 2013-06-30 | -5.60% |
| 2013-03-31 | -14.02% |
| 2012-12-31 | -15.27% |
| 2012-09-30 | -53.05% |
| 2012-06-30 | -15.23% |
| 2012-03-31 | -29.51% |
| 2011-12-31 | -97.79% |
| 2011-09-30 | -82.05% |
| 2011-06-30 | -129.76% |
| 2011-03-31 | -320.81% |
| 2010-12-31 | -1117.86% |
| 2010-09-30 | -2642.34% |
| 2010-06-30 | -837.25% |
| 2010-03-31 | -2735.70% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | -1991.58% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
